News

absorb, bioresorbable stents

DAIC readers chose the following stories as the most popular content in 2014, based on website analytics. The list is broken into the top 20 most popular news items from 2014 and a list of the top...

Tiara Transcatheter Mitral Valve, neovasc

Now that transcatheter aortic valve replacement (TAVR) is rapidly becoming an established treatment option, cardiology has shifted focus toward the next major frontier in interventional structural...

mitral regurgitation, Tendyne, TMVI System, clinical trial, heart valve repair

Tendyne Holdings Inc. announced that in November 2014, the Tendyne Transcatheter Mitral Valve Implantation system (TMVI) was successfully implanted in the first patient of the Tendyne Feasibility...

transcaval aortic valve replacement, TAVR

For patients transcatheter aortic valve replacement (TAVR) patients whose anatomy prevents the use of femoral artery access, use of a transcaval access route (accessing the femoral...

The most accessed research studies in the Journal of the American College of Cardiology (JACC) in 2014 spanned many topics, including a blood test to rule out heart attack, an advisory...

Atrial fibrillation, heart valve repair, software, mobile devices, ACC app

The American College of Cardiology’s recently released Guideline Clinical App has expanded with the addition of tools and guideline content for two conditions, valvular heart disease and...

Doctors at St. Joseph’s Children’s Hospital of Tampa implanted a Melody transcatheter pulmonary valve in a 13-year-old patient in October, marking the 50th time the hospital has given the device...

Medtronic, PERIGON Pivotal Trial, pericardial surgical aortic heart valve

Medtronic, Inc. announced it has initiated the PERIGON (PERIcardial SurGical AOrtic Valve ReplacemeNt) Pivotal Trial, a global, prospective clinical trial evaluating an investigational surgical...

Clinical Trial, Heart valve repair, TAVR

New research from the Minneapolis Heart Institute Foundation has uncovered a way to help interventional cardiologists better predict which patients are at higher risk for death following TAVR,...

Results from a new study indicate that the addition of mitral valve (MV) repair to coronary artery bypass grafting (CABG) did not result in significant benefit to the patient and was associated...

heart valve repair, Moderate Ischemic Mitral Regurgitation, NHLB

Routinely adding mitral valve repair to coronary artery bypass graft surgery for heart attack...

TriReme, PTA Chocolate Balloon, valvuloplasty, heart valve repair

Catalist-listed QT Vascular Ltd. has acquired a novel technology platform called Java, and all associated intellectual property, which was developed independently in Israel.

Sorin Group, heart valve repair, first implant

Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, implanted the Solo Smart surgical replacement performed by David Heimansohn, M.D., at St....

DAIC Editor Dave Fornell

The key take away messages from the 26th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium were bioresorable stents and transcatheter valve technologies will likely...

El Camino Hospital in Mountain View, California, became one of the first hospitals in California to adopt a new minimally invasive system to treat patients with narrowed, failing aortic...

Annie Henderson, 69, suffers from multiple chronic ailments, including kidney failure and mitral valve insufficiency. The latter turned her life into a battle for breath, eliminating almost all...

The U.S. Food and Drug Administration (FDA) approved the Sorin Freedom Solo and Solo Smart stentless heart valves from Sorin Group Canada Inc. to replace a diseased, damaged or malfunctioning...

Cardiothoracic and Vascular Surgeons became the first in Texas to implant the Solo Smart Aortic Pericardial Heart Valve. Faraz Kerendi, M.D. and Stephen J. Dewan M.D., performed the procedure at...

Neovasc Inc. has received conditional Investigational Device Exemption (IDE) approval from the U.S. FDA to initiate the U.S. arm of its Tiara-I Early Feasibility Trial for the company's Tiara...

October 10, 2014—Mitralign Inc. reported on the successful use of its technology to perform a percutaneous repair on a patient with tricuspid regurgitation (TR). Prof. Dr. med. J. Schofer of the...